The Effect of Frailty and Other Geriatric Syndromes on the Prognosis of Elderly Patients With Acute Coronary Syndrome
1 other identifier
observational
1,000
1 country
1
Brief Summary
This is a prospective observational clinical trail which will recruit 1000-1500 participants over 65 years with frailty and acute coronary syndrome (ACS) in Beijing Friendship hospital. The investigators will conduct frailty assessment (FRAIL scale, CFS, SPPB), comorbidities, functional status (Barthel index, ADL, IADL), nutritional risk (MNA-SF), and then observe the clinical outcomes of elderly ACS participants with frailty. Then, the investigators will follow-up these participants separately in 1,3,6 and 12months, the anticipate follow-up time is 1 year. According to the follow-up results, investigators will evaluate the impact of frailty and other senile syndromes on the short-term and long-term prognosis of ACS, and develop a scoring system for the prognosis evaluation of elderly ACS participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
September 11, 2020
CompletedFirst Posted
Study publicly available on registry
October 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedOctober 8, 2020
October 1, 2020
1.9 years
September 11, 2020
October 7, 2020
Conditions
Outcome Measures
Primary Outcomes (4)
Death
All-cause death and cardiac death events
During hospitalization, assessed up to 2 months
Major Adverse Cardiac and Cerebrovascular events
Major Adverse Cardiac and Cerebrovascular events including heart failure, cardiac shock, malignant arrhythmia, myocardial infarction, revascularization, and cerebral infarction
During hospitalization, assessed up to 2 months
Death
All-cause death and cardiac death events
1 year
Major Adverse Cardiac and Cerebrovascular events
Major Adverse Cardiac and Cerebrovascular events including heart failure, cardiac shock, malignant arrhythmia, myocardial infarction, revascularization, and cerebral infarction
1 year
Interventions
this is an observational study with none intervention
Eligibility Criteria
This registry will include consecutive patients age ≥65 years admitted for ACS
You may qualify if:
- Elderly participants over 65
- Clinical diagnosis of acute coronary syndrome
- Must be able to follow-up
- Sign in the informed consent
You may not qualify if:
- Myocardial infarction caused by other acute disease
- Mental disorders who cannot cooperate to complete the assessment
- Severe liver dysfunction, kidney disease (CKD 5), end-stage malignant tumor
- Totally disabled and bedridden
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Friendship hospital
Beijing, Beijing Municipality, 010, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of department geriatrics, Beijing Friendship Hospital
Study Record Dates
First Submitted
September 11, 2020
First Posted
October 8, 2020
Study Start
January 1, 2020
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
October 8, 2020
Record last verified: 2020-10